Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Swiss fund of hedge funds ALTIN flat in H1

Wednesday, August 31, 2011
ALTIN AG, the Swiss alternative investment company, has today published its half year results as at 30 June, 2011.

ALTIN AG is down 0.57% YTD (as at July 28th, 2011), compared to the HFRI FoF Composite index at +0.09% and the MSCI World Hedge Index at -1.34%.

Thanks to the active management of its underlying hedge fund strategies and good manager selection, ALTIN has been able to protect its investors’ portfolios during the first half of the year in 2011 and has significantly outperformed the HFRI FoF Composite and MSCI World Hedged indices since its launch, with an annualized performance of +7.18%. ALTIN’s portfolio, which comprises over 35 funds, is very liquid, enabling the fund manager to follow a dynamic management approach and to take advantage of investment opportunities.

(press release)

The half year report is available on the company’s web site: www.altin.ch/banque-SYZ-bank/reportsBrochures_1/


See our July article on ALTIN:
Swiss fund of hedge funds ALTIN flat in H1, adds CTA manager Welton to portfolio Source


Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its